Nico A. Kraus

Frankfurt Am Main, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Phospholipid-driven conformational switching of HCV NS5A links protein folding to replication membrane remodeling.

Phospholipid-driven conformational switching of HCV NS5A links protein folding to replication membrane remodeling.

Journal: Science advances

Published: April 03, 2026

Deletion of ABIN1-LIR motifs impairs hepatic lipid homeostasis and mitophagy via AMPK-TFEB axis in mice.

Deletion of ABIN1-LIR motifs impairs hepatic lipid homeostasis and mitophagy via AMPK-TFEB axis in mice.

Journal: American journal of physiology. Cell physiology

Published: September 08, 2025

Metabolic Signatures of Acinetobacter baumannii and Klebsiella pneumoniae Infections in Acute-on-chronic Liver Failure.

Metabolic Signatures of Acinetobacter baumannii and Klebsiella pneumoniae Infections in Acute-on-chronic Liver Failure.

Journal: Cellular and molecular gastroenterology and hepatology

Published: August 22, 2025

Enterococcus faecium DNA in acute decompensated cirrhosis: a key player in inflammation and kidney dysfunction.

Enterococcus faecium DNA in acute decompensated cirrhosis: a key player in inflammation and kidney dysfunction.

Journal: Frontiers in medicine

Published: May 15, 2025

Higher prevalence of cytomegalovirus and Epstein-Barr virus in acute-on-chronic liver failure.

Higher prevalence of cytomegalovirus and Epstein-Barr virus in acute-on-chronic liver failure.

Journal: JHEP reports : innovation in hepatology

Published: March 20, 2025

Wanted: Dead or Alive Cells with Propidium Iodide Staining in Liver Tissue.

Wanted: Dead or Alive Cells with Propidium Iodide Staining in Liver Tissue.

Journal: International journal of molecular sciences

Published: October 29, 2024

Decompensated MASH-Cirrhosis Model by Acute and Toxic Effects of Phenobarbital.

Decompensated MASH-Cirrhosis Model by Acute and Toxic Effects of Phenobarbital.

Journal: Cells

Published: July 23, 2024

BI-3231, an enzymatic inhibitor of HSD17B13, reduces lipotoxic effects induced by palmitic acid in murine and human hepatocytes.

BI-3231, an enzymatic inhibitor of HSD17B13, reduces lipotoxic effects induced by palmitic acid in murine and human hepatocytes.

Journal: American journal of physiology. Cell physiology

Published: January 15, 2024

The Role of Hypoxia-Inducible Factor 1 Alpha in Acute-on-Chronic Liver Failure.

The Role of Hypoxia-Inducible Factor 1 Alpha in Acute-on-Chronic Liver Failure.

Journal: International journal of molecular sciences

Published: December 17, 2023

Differential Lipidomics, Metabolomics and Immunological Analysis of Alcoholic and Non-Alcoholic Steatohepatitis in Mice.

Differential Lipidomics, Metabolomics and Immunological Analysis of Alcoholic and Non-Alcoholic Steatohepatitis in Mice.

Journal: International journal of molecular sciences

Published: May 24, 2023

Neprilysin-dependent neuropeptide Y cleavage in the liver promotes fibrosis by blocking NPY-receptor 1.

Neprilysin-dependent neuropeptide Y cleavage in the liver promotes fibrosis by blocking NPY-receptor 1.

Journal: Cell reports

Published: July 23, 2022

Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis.

Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis.

Journal: Hepatology (Baltimore, Md.)

Published: February 02, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026